| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0005 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0006 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.18 | 0.001 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | -0.094 | 0.004 |